Journal article icon

Journal article

The relationship of provider organizational status and erythropoietin dosing in end stage renal disease patients.

Abstract:

Controversy exists as to whether provider organizational characteristics such as profit status and setting are associated with the content of medical care or efficiency with which care is rendered. Following FDA approval of human recombinant erythropoietin (EPO) for use in clinical practice, Medicare approved coverage for beneficiaries in its end stage renal disease program and established a fixed payment per dose. Because cost of EPO administration varied positively with dose, providers coul...

Expand abstract

Actions


Access Document


Authors


Expand authors...
Journal:
Medical care
Volume:
32
Issue:
2
Pages:
130-140
Publication date:
1994-02-05
DOI:
EISSN:
1537-1948
ISSN:
0025-7079
URN:
uuid:6e0911cb-a479-4800-bad5-599c1a8e0755
Source identifiers:
359137
Local pid:
pubs:359137

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP